When surveilling cirrhosis-stricken patients for hepatocellular carcinoma—or HCC, the frequently incurable cancer that starts in the liver and sometimes follows cirrhosis—MRI with liver-specific contrast can be a better diagnostic performer than ultrasound, the guideline-recommended screening tool for such situations. 

Computer-aided detection (CAD) may be useful as a “second reader” of low-dose CT lung images, as four CAD systems in a small study found up to 70 percent of lung cancers a radiologist had missed yet missed around 20 percent of cancers that human eyes had caught.

… It helps quite a lot if he or she has family, faith—and a pioneering radiosurgery/neurosurgery colleague as a close friend and confidante. 

Second-opinion interpretations of neuroimaging studies by subspecialized oncologic neuroradiologists can significantly cut error rates and, in the process, improve cancer care, according to the authors of a study published in the Sept. 1 issue of the biweekly journal Cancer.

When an MRI turned up cancer in four parts of his brain a year ago, Jimmy Carter thought his end was near. 

Intraoperative MRI (ioMRI) soon may be must-have technology for many if not most neurosurgical suites, but those looking to take the plunge for their brain-tumor service line should expect longer procedure times and more scrupulous pre-operative room preparation.

Gadolinium-based contrast agents (GBCAs) have shown up as bright signals, or “hyperintensities,” in T1-weighted MR brain images of patients with no such contrast administered at present but 35 or more linear GBCA doses in the past. 

New research from Columbia University shows that patients who’ve suffered from cancer may have a harder time warding off extra pounds, and it may be even more difficult for patients of color.